Skip to content

MOBILE Intervention in College Students With Elevated Blood Pressure

MOBILE Intervention in College Students With Elevated Blood Pressure: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05956925
Acronym
MOBILE
Enrollment
29
Registered
2023-07-24
Start date
2020-12-03
Completion date
2022-06-30
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

mhealth, hypertension, college students, self-monitoring, lifestyle modifications

Brief summary

The investigators' long-term goal is to develop tailored interventions to influence self-management behaviors in young adults with elevated blood pressure (BP). The investigators seek to test an intervention, mobile health (mHealth) to Optimize BP Improvement (MOBILE), that takes advantage of existing applications and our prior work to allow participants to (1) perform self-measured BP monitoring; (2) receive feedback from a cloud-based cardiovascular disease (CVD) detection platform; and (3) receive tailored text messages that encourage engagement in BP reduction behavior. mHealth technology provides an ideal way to deliver healthcare interventions to young adults. Text messaging is especially appealing to college students, more than 91% of whom use smartphones as their main communication device. For this study, the investigators will recruit 42 college students, ages 18 to 29, with elevated BP to participate in formative developmental project and then a 4-week two-armed trial of MOBILE. The aims of this study are: Aim 1. To refine the MOBILE intervention during a formative phase involving 8-10 students. Outcomes will include finalized motivation-level-tailored text messages designed to prompt behavior change and a self-administered motivational scale to be employed in the Aim 2 and Exploratory Aim study. Aim 2. To evaluate the feasibility of implementing the MOBILE intervention in 32 college students with elevated BP. The investigators will operationalize MOBILE feasibility as: (a) acceptability to participants, (b) participation rate, (c) texts delivered and opened, (d) fidelity to daily BP measurement protocol, (e) reported technical problems and challenges, and (f) recruitment and attrition rates. Exploratory Aim. To examine the preliminary impact of the MOBILE intervention on BP reduction (primary outcome) along with sodium intake and hypertension (HTN) knowledge improvement (secondary outcomes) among 32 college students with elevated BP. Hypothesis: The intervention group will have a significantly greater reduction in BP and sodium intake and greater increase in HTN knowledge from baseline to completion, compared to control group.

Detailed description

The investigators seek to test an intervention, mHealth to Optimize BP Improvement (MOBILE), that takes advantage of existing applications and our prior work to allow participants to (1) perform self-measured BP monitoring; (2) receive feedback from a cloud-based CVD detection platform; and (3) receive tailored text messages that encourage engagement in BP reduction behavior. mHealth technology provides an ideal way to deliver healthcare interventions to young adults.

Interventions

BEHAVIORALIntervention group was asked to take their BP daily and rate their motivation level and communicate with the research assistant. Their level will trigger the appropriate behavioral change SMS prompt.

The investigators showed participants how to use the Health Mate app, upload Withings BP cuff readings, upload historical data to the cloud, read trend lines in their record, rank their daily motivational level, and answer a brief short message service (SMS) question about whether the participants completed the behavioral change task encouraged by the daily message. A one-page instruction sheet with the research team's contact information was provided. Participants were instructed to take their BP daily, before their first meal and encouraged to avoid prior alcohol and caffeine intake as well as physical activity. The participants were instructed to rate their motivational level as low, moderate, or high via SMS when transmitting their BP value. Their level will trigger the appropriate behavioral change SMS prompt.

Sponsors

University of Nevada, Las Vegas
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Masking description

No masking was done.

Intervention model description

Intervention group vs control group

Eligibility

Sex/Gender
ALL
Age
18 Years to 29 Years
Healthy volunteers
No

Inclusion criteria

Aim 1 Formative Phase: * Full-time (≥ 12 credits for undergraduate and ≥ 9 credits for graduate) college student at the University of Nevada, Las Vegas (UNLV) * Aged 18-29 years. Aim 2 Inclusion criteria: * Full-time (≥ 12 credits for undergraduate and ≥ 9 credits for graduate) college student at UNLV * Aged 18-29 years * Regular access to a mobile smart-phone with unlimited texting * Elevated BP (SBP 120-129 mm Hg and diastolic blood pressure \[DBP\] \<80 mm Hg) or undiagnosed HTN stage 1 (SBP 130-139 mm Hg or DBP 80-89 mm Hg). Interested participants who have HTN stage 2 (SBP \>140 mm Hg or DBP \>90 mm Hg) will need clearance from their primary healthcare provider to participate in the study.

Exclusion criteria

Aim 2

Design outcomes

Primary

MeasureTime frameDescription
BP LevelAverage value from 28 daysBP level (systolic and diastolic BP) was taken using the Withings Wireless BP cuff by the participant in the intervention group.

Secondary

MeasureTime frameDescription
Sodium IntakeAverage of Day 1 and Day 28ASA24 dietary intake were measured in all participants and sodium intake was evaluated using this measurement.
HTN KnowledgeAverage of Day 1 and Day 28Assess all participants' knowledge on HTN using the Hypertension Knowledge-Level Scale (HK-LS). 6 sub-dimensions: definition, medical treatment, drug compliance, lifestyle, diet, and complications 22-item; Responses; Score ranges from 0-22; Higher scores reflect greater knowledge of HTN. Reliability: Cronbach's alpha 0.82 & Validity: good content, face, and construct validity, test re-test reliability (0.79), and discriminative validity (0.27-\>0.40).

Countries

United States

Participant flow

Pre-assignment details

Participants who had HTN stage II (SBP \>140 mm Hg or DBP \>90 mm Hg) during screening and enrollment, but did not provide a health care provider note were not assigned to a group.

Participants by arm

ArmCount
Control
Following the educational session, the control group participants' BP, ASA24® Dietary Assessment Tool (ASA24; sodium intake), and pre-test knowledge on HTN will be obtained (using Qualitrics). Four weeks later, the participants were scheduled for a follow-up meeting to collect each participant's BP, ASA24, and post-test knowledge on HTN (using Qualitrics).
14
MOBILE Intervention Group
Intervention participants were required to take daily BP, provide their motivation level, and send them to the research assistant to receive the appropriate text messages. Intervention group was asked to take their BP daily and rate their motivation level and communicate with the research assistant. Their level will trigger the appropriate behavioral change SMS prompt.: The investigators showed participants how to use the Health Mate app, upload Withings BP cuff readings, upload historical data to the cloud, read trend lines in their record, rank their daily motivational level, and answer a brief short message service (SMS) question about whether the participants completed the behavioral change task encouraged by the daily message. A one-page instruction sheet with the research team's contact information was provided. Participants were instructed to take their BP daily, before their first meal and encouraged to avoid prior alcohol and caffeine intake as well as physical activity. The participants were instructed to rate their motivational level as low, moderate, or high via SMS when transmitting their BP value. Their level will trigger the appropriate behavioral change SMS prompt.
15
Total29

Baseline characteristics

CharacteristicControlMOBILE Intervention GroupTotal
Age, Customized
Mean
21.7 years
STANDARD_DEVIATION 2.4
24.1 years
STANDARD_DEVIATION 3.03
22.9 years
STANDARD_DEVIATION 2.95
Blood Pressure
Diastolic Blood Pressure
80.9 mm Hg
STANDARD_DEVIATION 9.01
80.6 mm Hg
STANDARD_DEVIATION 8.7
80.7 mm Hg
STANDARD_DEVIATION 8.69
Blood Pressure
Systolic Blood Pressure
125.5 mm Hg
STANDARD_DEVIATION 12.04
131.2 mm Hg
STANDARD_DEVIATION 11.3
128.45 mm Hg
STANDARD_DEVIATION 11.81
Body mass index category
Normal or Healthy Weight
3 Participants4 Participants7 Participants
Body mass index category
Obese
6 Participants4 Participants10 Participants
Body mass index category
Overweight
4 Participants7 Participants11 Participants
Body mass index category
Underweight
1 Participants0 Participants1 Participants
Daily Caloric Intake1874.2 calories
STANDARD_DEVIATION 752.16
2446.5 calories
STANDARD_DEVIATION 1425.86
2160.38 calories
STANDARD_DEVIATION 1155.95
Daily Sodium Intake3765.5 mg
STANDARD_DEVIATION 1953.08
3955.4 mg
STANDARD_DEVIATION 2530.53
3863.77 mg
STANDARD_DEVIATION 2232.07
Education
Graduate
0 Participants9 Participants9 Participants
Education
Undergraduate
14 Participants6 Participants20 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
6 Participants6 Participants12 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
8 Participants9 Participants17 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Family History of Heart Disease8 Participants4 Participants12 Participants
Hypertension Knowledge-Level Scale (HK-LS)17.14 units on a scale
STANDARD_DEVIATION 2.48
17.87 units on a scale
STANDARD_DEVIATION 3.07
17.52 units on a scale
STANDARD_DEVIATION 2.77
Insurance coverage12 Participants12 Participants24 Participants
Martial Status
Divorced/Separated
0 Participants1 Participants1 Participants
Martial Status
Married or living together
2 Participants3 Participants5 Participants
Martial Status
Single
12 Participants11 Participants23 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
5 Participants3 Participants8 Participants
Race (NIH/OMB)
Black or African American
1 Participants0 Participants1 Participants
Race (NIH/OMB)
More than one race
2 Participants4 Participants6 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
6 Participants8 Participants14 Participants
Region of Enrollment
United States
14 participants15 participants29 participants
Sex: Female, Male
Female
7 Participants9 Participants16 Participants
Sex: Female, Male
Male
7 Participants6 Participants13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 140 / 15
other
Total, other adverse events
0 / 140 / 15
serious
Total, serious adverse events
0 / 140 / 15

Outcome results

Primary

BP Level

BP level (systolic and diastolic BP) was taken using the Withings Wireless BP cuff by the participant in the intervention group.

Time frame: Average value from 28 days

Population: College students between ages 18-29

ArmMeasureGroupValue (MEAN)Dispersion
ControlBP LevelSystolic Blood Pressure124.0 mm HgStandard Deviation 12.31
ControlBP LevelDiastolic Blood Pressure77.9 mm HgStandard Deviation 7.9
MOBILE Intervention GroupBP LevelSystolic Blood Pressure118.7 mm HgStandard Deviation 11.32
MOBILE Intervention GroupBP LevelDiastolic Blood Pressure73.7 mm HgStandard Deviation 7.6
Secondary

HTN Knowledge

Assess all participants' knowledge on HTN using the Hypertension Knowledge-Level Scale (HK-LS). 6 sub-dimensions: definition, medical treatment, drug compliance, lifestyle, diet, and complications 22-item; Responses; Score ranges from 0-22; Higher scores reflect greater knowledge of HTN. Reliability: Cronbach's alpha 0.82 & Validity: good content, face, and construct validity, test re-test reliability (0.79), and discriminative validity (0.27-\>0.40).

Time frame: Average of Day 1 and Day 28

ArmMeasureValue (MEAN)Dispersion
ControlHTN Knowledge19.1 units on a scaleStandard Deviation 1.54
MOBILE Intervention GroupHTN Knowledge19.3 units on a scaleStandard Deviation 1.35
Secondary

Sodium Intake

ASA24 dietary intake were measured in all participants and sodium intake was evaluated using this measurement.

Time frame: Average of Day 1 and Day 28

Population: College students between the ages of 18-29.

ArmMeasureValue (MEAN)Dispersion
ControlSodium Intake3046.2 mgStandard Deviation 1095.85
MOBILE Intervention GroupSodium Intake3799.39 mgStandard Deviation 2540.8

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026